Press Releases
2/16/2022
ImmunoScape Inks Licensing Deal with Pure MHC to Advance Development of Novel TCRBased Therapies
Access Our Innovation Engine
2/16/2022
ImmunoScape Inks Licensing Deal with Pure MHC to Advance Development of Novel TCRBased Therapies
7500 Rialto Blvd.
Bldg. 2, Ste. 260
Austin, Texas 78735
© 2020 | All Rights Reserved.